A 7-week Phase III trial of diclofenac gel (Pennsaid 2%) in Russia

Trial Profile

A 7-week Phase III trial of diclofenac gel (Pennsaid 2%) in Russia

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Nov 2015

At a glance

  • Drugs Diclofenac (Primary)
  • Indications Osteoarthritis
  • Focus Registrational; Therapeutic Use
  • Sponsors NovaMedica
  • Most Recent Events

    • 05 Nov 2015 According to Nuvo Research media release, this study met required endpoints.
    • 05 Nov 2015 Status changed from recruiting to completed, as per Nuvo Research media release.
    • 16 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top